Topoisomerase IIα Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu–Amplified Breast Ca... von TANNER, Minna, ISOLA, Forma, WIKLUND, Tom, ERIKSTEIN, Björn, KELLOKUMPU-LEHTINEN, Pirkko, MALMSTRÖM, Per, WILKING, Nils, NILSSON, Jonas, BERGH, Jonas

Volltext

Basoluminal Carcinoma: A New Biologically and Prognostically Distinct Entity Between Basal and Luminal Breast Cancer von Laakso, Mervi, Tanner, Minna, Nilsson, Jonas, Wiklund, Tom, Erikstein, Björn, Kellokumpu-Lehtinen, Pirkko, Malmström, Per, Wilking, Nils, Bergh, Jonas, Isola, Jorma

Volltext

Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer von LØNNING, Per E, GEISLER, Jürgen, POLLI, Anna, MASSIMINI, Giorgio, KRAG, Lars E, ERIKSTEIN, Bjørn, BREMNES, Yngve, HAGEN, Anne I, SCHLICHTING, Ellen, LIEN, Ernst A, ØFJORD, Erik S, PAOLINI, Jolanda

Volltext

Genetic variants of CYP19 (aromatase) and breast cancer risk von KRISTENSEN, V. N, HARADA, N, YOSHIMURA, N, HARALDSEN, E, LØNNING, P. E, ERIKSTEIN, B, KARESEN, R, KRISTENSEN, T, BØRRESEN-DALE, A.-L

Volltext

Germline glutathione S-transferase variants in breast cancer: Relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy von Edvardsen, Hege, M.Sc, Kristensen, Vessela N., Ph.D, Grenaker Alnaes, Grethe Irene, B.Sc, Bøhn, Mona, Erikstein, Bjørn, M.D. Ph.D, Helland, Åslaug, M.D., Ph.D, Børresen-Dale, Anne-Lise, Ph.D, Fosså, Sophie Dorothea, M.D., Ph.D

Volltext

Quantitative Analysis of Chromosomal CGH in Human Breast Tumors Associates Copy Number Abnormalities with p53 Status and Patient Survival von Jain, Ajay N., Chin, Koei, Børresen-Dale, Anne-Lise, Erikstein, Bjorn K., Lonning, Per Eystein, Kaaresen, Rolf, Gray, Joe W.

Volltext

Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: Results of a double-blind randomized study von Smeland, Sigbjørn, Erikstein, Bjørn, Aas, Magne, Skovlund, Eva, Hess, Siri Lothe, Fosså, Sophie Dorothea

Volltext

Quality of Life in Women With Breast Cancer During the First Year After Random Assignment to Adjuvant Treatment With Marrow-Supported High-Dose Chemotherapy With Cyclophosphamide,... von BRANDBERG, Yvonne, MICHELSON, Helena, BERGH, Jonas, NILSSON, Bo, BOLUND, Christina, ERIKSTEIN, Bjørn, HIETANEN, Päivi, KAASA, Stein, NILSSON, Jonas, WIKLUND, Tom, WILKING, Nils

Volltext

CYP17 and breast cancer risk : The polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1 von KRISTENSEN, V. N, HARALDSEN, E. K, ANDERSON, K. B, LØNNING, P. E, ERIKSTEIN, B, KARESEN, R, GABRIELSEN, O. S, BØRRESEN-DALE, A.-L

Volltext

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial von Bergh, Jonas, Wiklund, Tom, Erikstein, Björn, Lidbrink, Elisabet, Lindman, Henrik, Malmström, Per, Kellokumpu-Lehtinen, Pirkko, Bengtsson, Nils-Olof, Söderlund, Gustaf, Anker, Gun, Wist, Erik, Ottosson, Susanne, Salminen, Eeva, Ljungman, Per, Holte, Harald, Nilsson, Jonas, Blomqvist, Carl, Wilking, Nils

Volltext

The Potential for Aromatase Inhibition in Breast Cancer Prevention von Per E. Lønning, Lars Erik Kragh, Bjørn Erikstein, Anne Hagen, Terje Risberg, Ellen Schlichting, Jürgen Geisler

Volltext

Pharmacokinetic profile of intramuscular fulvestrant in advanced breast cancer von ROBERTSON, John F. R, ERIKSTEIN, Bjorn, OSBORNE, Kent C, PIPPEN, John, COME, Steven E, PARKER, Leroy M, GERTLER, Stan, HARRISON, Mike P, CLARKE, David A

Volltext

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy von Wilking, N, Lidbrink, E, Wiklund, T, Erikstein, B, Lindman, H, Malmström, P, Kellokumpu-Lehtinen, P, Bengtsson, N-O, Söderlund, G, Anker, G, Wist, E, Ottosson, S, Salminen, E, Ljungman, P, Holte, H, Nilsson, J, Blomqvist, C, Bergh, J

Volltext

Independent regulation of 55‐kDa and 75‐kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes von Erikstein, Bjørn K., Smeland, Erlend B., Blomhoff, Heidi Kiil, Funderud, Steinar, Prydz, Kristian, Lesslauer, Werner, Espevik, Terje

Volltext

Monitoring of disseminated tumor cells in bone marrow in high‐risk breast cancer patients treated with high‐dose chemotherapy von Drageset, Vilde, Nesland, Jahn M., Erikstein, Bjorn, Skovlund, Eva, Sommer, Hilde, Anker, Gun, Wist, Erik, Lundgren, Steinar, Bergh, Jonas, Kvalheim, Gunnar

Volltext

Elevated CA 125 in Breast Cancer – A Sign of Advanced Disease von Norum, Lars F., Erikstein, Bjørn, Nustad, Kjell

Volltext

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breas... von Tanner, Minna, Isola, Jorma, Wiklund, Tom, Erikstein, Björn, Kellokumpu-Lehtinen, Pirkko, Malmström, Per, Wilking, Nils, Nilsson, Jonas, Bergh, Jonas

Volltext

In Reply von Brandberg, Yvonne, Lidbrink, Elisabet, Michelson, Helena, Wilking, Nils, Bergh, Jonas, Wiklund, Tom, Erikstein, Bjørn

Volltext

Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells von Blomhoff, H K, Smeland, E B, Erikstein, B, Rasmussen, A M, Skrede, B, Skjønsberg, C, Blomhoff, R

Volltext

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: A randomised von Bergh, Jonas, Wiklund, Tom, Erikstein, Bjorn, Lidbrink, Elisabet

Volltext